These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21570678)

  • 1. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.
    Kesselring R; Thiel A; Pries R; Wollenberg B
    Cell Immunol; 2011; 269(2):74-7. PubMed ID: 21570678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transient nature of the Th17 phenotype.
    Annunziato F; Romagnani S
    Eur J Immunol; 2010 Dec; 40(12):3312-6. PubMed ID: 21110314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
    Milanovich MR; Snyderman CH; Wagner R; Johnson JT
    Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
    Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
    Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in head and neck cancer.
    Pries R; Wollenberg B
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
    Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
    Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
    Young MR; Levingston CA; Johnson SD
    Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.
    Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H
    Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
    Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
    Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
    Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
    Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
    Crome SQ; Wang AY; Kang CY; Levings MK
    Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cells in inflammation.
    Kimura A; Kishimoto T
    Int Immunopharmacol; 2011 Mar; 11(3):319-22. PubMed ID: 21035432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.
    Li C; Zhao Y; Zhang W; Zhang W
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):81-9. PubMed ID: 21458322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
    Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
    J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.